GlassScriptPhysician profile
Brad S Sorosky
NPI 1790706836
$3,972.04
in general payments reported to CMS, 2019-2025
24 companies · $843 in 2025
The $843 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $414 · 2021: $550 · 2022: $245 · 2023: $255 · 2024: $220 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,974.86 | 2019-2025 | Proclaim, Prodigy, Octrode |
| Depuy Synthes Products, INC. | $870.00 | 2019 | |
| Medtronic USA, INC. | $152.87 | 2019-2020 | |
| Lundbeck LLC | $148.90 | 2025 | Vyepti |
| Medtronic, INC. | $119.33 | 2022-2025 | Kyphon Express II Kyphopak Tray |
| Allergan, INC. | $107.65 | 2019 | |
| Abbvie INC. | $91.27 | 2022 | |
| Boston Scientific Corporation | $66.71 | 2019-2025 | Intracept Rf Probe |
| Averitas Pharma INC. | $56.25 | 2024-2025 | Qutenza |
| Bioventus LLC | $55.10 | 2020-2025 | Durolane |
| Si-Bone, INC. | $51.57 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.46 | 2020 | |
| Nuvasive, INC. | $33.41 | 2023 | Acp |
| Pacira Pharmaceuticals Incorporated | $28.72 | 2024 | Iovera |
| Avanos Medical | $24.40 | 2025 | Generator |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $22.26 | 2025 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $21.20 | 2019 | |
| Globus Medical, INC. | $21.02 | 2025 | Senza |
| Nevro Corp. | $20.80 | 2019 | |
| Otto Bock Healthcare LP | $18.71 | 2020 | |
| Depuy Synthes Sales INC. | $16.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.40 | 2019 | |
| Sonex Health, INC. | $10.50 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Sorosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.